SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-24-015674
Filing Date
2024-04-23
Accepted
2024-04-23 13:46:05
Documents
6

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 659903
2 ex4-7.htm EX-4.7 556251
3 ex5-1.htm EX-5.1 44475
4 ex23-1.htm EX-23.1 4631
5 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 25831
6 forms-3_001.jpg GRAPHIC 6299
  Complete submission text file 0001493152-24-015674.txt   1300900
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278874 | Film No.: 24863808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)